Filter
226
Text search:
pharmacological
interventions
Featured
Recommendations
36
New Publications
38
Language
Document type
No document type
135
Guidelines
34
Studies & Reports
22
Manuals
15
Training Material
7
Strategic & Response Plan
6
Fact sheets
5
Situation Updates
1
Resource Platforms
1
Countries / Regions
Global
11
India
8
Kenya
8
Western and Central Europe
8
South Africa
6
Latin America and the Carribbean
6
Eastern Europe
5
Rwanda
4
Nigeria
3
Ethiopia
3
Asia
3
Uganda
2
Zimbabwe
2
Syria
2
Ukraine
2
Russia
2
Guinea
1
Sierra Leone
1
Liberia
1
Senegal
1
Ghana
1
Philippines
1
Nepal
1
South Sudan
1
Jordan
1
Germany
1
Tanzania
1
Cambodia
1
Bangladesh
1
Papua New Guinea
1
Peru
1
Eswatini/ Swaziland
1
Hungary
1
Lesotho
1
Middle East and North Africa
1
South–East Asia Region
1
Africa
1
Poland
1
Uzbekistan
1
Gabon
1
Turkmenistan
1
Authors & Publishers
Publication Years
Category
Countries
44
Clinical Guidelines
35
Public Health
15
Women & Child Health
13
Capacity Building
3
Pharmacy & Technologies
3
Key Resources
2
Toolboxes
Mental Health
92
NCDs
17
COVID-19
9
TB
8
Caregiver
7
Pharmacy
7
HIV
6
AMR
6
Refugee
4
NTDs
3
Disability
2
Conflict
2
Planetary Health
2
Ebola & Marburg
1
Polio
1
Natural Hazards
1
Zika
1
Specific Hazards
1
Global Health Education
1
Social Ethics
1
Assessing Mental Health and Psychosocial Needs and Resources Toolkit For Humanitarian Settings
recommended
Available in different languages: English, French, Arabic, Russian
In recent years, high prices of pharmaceutical products have posed challenges in high- and low-income countries alike. In many instances, high prices of pharmaceutical products have led to significant financial hardship for individuals and negatively impacted on healthcare systems’ ability to prov
...
Inequality of access to palliative care and symptom relief is one of the greatest disparities in global health care (1). Currently, there is avoidable suffering on a massive scale due to lack of access to palliative care and symptom relief in low- and middle-income countries (LMICs) (1). Yet basic p
...
Otros trastornos
Capítulo H.5.1
Edición: Matías Irarrázaval & Andres Martin
Traductores: Fernanda Prieto-Tagle & Iván Olle Llopis
This report explores community-focused change initiatives in the financing, organization, and delivery of mental health services in Peru from 2013 to 2016. It examines the national dimension of reforms but focuses above all on implementation and results in the economically fragile district of Caraba
...
Le trouble anxiété de séparation (TAS) représente environ la moitié de l’ensemble des troubles anxieux
(Cartwright-Harton et al, 2006). La plupart des troubles anxieux pédiatriques
présentent les mêmes critères diagnostics que chez l’adulte à l’exception du TAS,
actuellement class
...
Mood disorders
Chapter E.3
2016 edition
In 2015, WHO proposed the use of the Robson classification (also known as the 10-group classification) as a global standard for assessing, monitoring and comparing caesarean section rates both within healthcare facilities and between them. The system classifies all women into one of 10 categories t
...
The Mapping Antimicrobial Resistance and Antimicrobial Use Partnership (MAAP) project has conducted a multi-year, multi-country study that provides stark insights on the under-reported depth of the antimicrobial resistance (AMR) crisis across Africa and lays out urgent policy recommendations to addr
...
Trastornos del desarrollo
Capítulo C.4
A guide for doctors providing health services for children. 2nd edition
Master of Science in Pharmaceutical Management Dissertation
This publication gives a broad vision of what a comprehensive approach to cervical cancer prevention and control means. In particular, it outlines the complementary strategies for comprehensive cervical cancer prevention and control, and highlights the neners. This new guide updates the 2006 edition
...
November 3, 2009https://doi.org/10.1371/journal.pmed.1000176
PLoS Med 6(11): e1000176. https://doi.org/10.1371/journal.pmed.1000176
WHO and UNITAID
in collaboration with IMPAACT (International Maternal Pediatric Adolescent AIDS Clinical Trials) network, PENTA (Paediatric European Network for Treatment of AIDS) foundation and experts from the Paediatric Antiretroviral Working Group
Guide des pratiques essentielles
